Drug Delivery to the Lungs (DDL 2020)

9-11 December | Edinburgh, Scotland

Proveris is a Sponsor of Drug Delivery to the Lungs (DDL) 2020. We’ll showcase our latest technology solutions and laboratory services for Orally Inhaled and Nasal Drug Products (OINDPs). We’ll present study results in the Scientific Poster Session and host meetings in our private meeting room.

To schedule a meeting with us to discuss how we can help address your current challenges in OINDP development, email contactus@proveris.com.

DDL provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.

The Aerosol Society Website

Respiratory Drug Delivery Asia 2020 (RDD Asia 2020)

4 – 6 November | Goa, India

Proveris is a Sponsor of the Respiratory Drug Delivery (RDD) Asia 2020. At our exhibit stand we’ll showcase our latest technology solutions and laboratory services for Orally Inhaled and Nasal Drug Products (OINDPs). We’ll present study results in the Scientific Poster Session and host an Educational Workshop.

To schedule a meeting with us to discuss how we can help address your current challenges in OINDP development, email contactus@proveris.com.

Respiratory Drug Delivery, RDD®, hosts conferences in the US, Europe and Asia provide a venue for expert speakers to cover topics including: new therapeutic opportunities and drug delivery technologies, regulatory science and novel in vitro, in vivo and clinical testing methods.

Respiratory Drug Delivery Asia 2020 Website

9th Medicon Valley Inhalation Symposium, MVIS 2020

October 2020 | Lund, Sweden

Proveris’s European Sales Director, Dr. Deborah Jones, will attend the Medicon Valley Consortium Symposium. If you would like to arrange a meeting with her, please email us at contactus@proveris.com.

Medicon Valley Inhalation Symposium focuses on future opportunities in inhalation and provides attendees with the opportunity to explore various aspects relating to the topic of inhalation.

Medicon Valley Inhalation Consortium 2020

Aerosol School – Canceled

23 -25 September | Edmonton

Proveris Founder and CEO, Dino Farina and Senior Applications Scientist, Linda Liao will participate as instructors in the Aerosol School. In its 11th year, the program offers a wealth of knowledge through two components: lectures and in-lab learning. If you would like to learn more, please email us at contactus@proveris.com or visit the school website aerosolschool.com

The Aerosol School, co-organized by ISAM/St Joseph’s Healthcare/McMaster University Firestone Institute for Respiratory Health’s (FIRH), is a three-day teaching program, led by Prof. Myrna Dolovich. It offers expert information and training in the field of medical aerosols. Through the program, participants learn the range of measurements, techniques and approaches to drug development and inhaler design used in academic laboratories and pharmaceutical industry aerosol labs.

Innovative Drug Delivery Solutions Summit (IDDS 2020)

September 2020 | China

Proveris’s Senior Field Applications Scientist, Linda Liao and Local Sales Representative, Ruty Li will attend the Innovative Drug Delivery Solution Summit.

Please email us at contactus@proveris.com if you would like to arrange a meeting with them during the summit, or to request additional information.

IDDS is a bi-annual symposium that attracts leading experts and major players that focus on respiratory, ophthalmic, dermal, and various delivery routes. It shares global market and regulatory trends, provides insights into Chinese related regulations and practices, while showcasing drug delivery solutions and technologies.

Lung Inhalation Drug Delivery Technology Seminar

June 9, 2020 | China. 

Proveris’s Local Sales Agent, Ruty Li will attend the Lung Inhalation China Symposium and give a presentation on behalf of Proveris.

Please email us at contactus@proveris.com if you would like to arrange a meeting with Ruty Li during the symposium, or to request additional information

Pushing Through the Uncertainty: New in vitro Analytic Tools to Help Keep Your Development Projects on Track

Pushing Through the Uncertainty: New in vitro Analytical Tools to Help Keep Your Development Projects on Track

DATE & TIME:
 Wednesday May 27, 2020

9:00 am, New York, USA EDT

2:00 pm, London, UK BST | 6:30 pm, New Delhi, India IST | 9:00 pm, Beijing, China CST

What time is this for me?

PRESENTERS
Alberto Correia, VP Technical Services
Linda Liao, Senior Field Applications Scientist

Drug development costs are reported to exceed $1B USD, with daily revenues ranging from $1-3M. Shortening the time to market is critical to maximize return and secure a competitive advantage. Strategies that increase efficiencies and reduce cost are paramount.

For generic drug development in the OINDP space, striving toward a waiver of clinical endpoint testing is a route many are exploring. The FDA has shown commitment to this approach with its release of a product-specific guidance document highlighting alternative in vitro tests to demonstrate bioequivalence.

Innovator drug developers can also benefit from the data generated using these novel techniques to help guide key decisions early on regarding device selection, formulation development, and IVIVC.

In this webinar we will review the current landscape and discuss new tools and techniques that can be used to accelerate your development projects. We will demonstrate the importance of employing new in vitro analytical methods early on in your OINDP development projects in order to gain valuable insight and reach approval faster than you thought possible.

DETAILS AND REGISTRATION

Proveris Laboratories offers OINDP development expertise to biopharmaceutical companies, including contract services using new innovative techniques. Register to gain access to scientific data demonstrating how these novel tools are being used by Proveris to assist in maintaining projects and accelerating development.

Key takeaways:

  • How Proveris can assist in maintaining your projects or accelerating development
  • Overview of the major challenges in OINDP development
  • Discover a combination of new analytical techniques for comprehensive product insight which can be used to demonstrate in vitro bioequivalence and IVIVC
  • Understand the importance of applying alternative in vitro approaches early on in drug development
  • Learn more about updates to the regulatory guidance and the new landscape for generic drug development
  • Combine strategies to accelerate your development project and increase chances of successful approval

Who will benefit from attending:

  • Analytical R&D Scientists
  • R&D Directors
  • Lab Managers
  • Device Development Engineers
  • Formulation Development Scientists
  • Product Development Teams
  • Regulatory Managers and Directors

Nasal Drug Delivery 2020 – Canceled

14-15 May 2020 | London, UK

Proveris’s European Sales Director, Dr. Deborah Jones, will attend both days of the Nasal Drug Delivery Conference. If you would like to arrange a meeting with her, please email us at contactus@proveris.com.

The Nasal Drug Delivery Conference gives a comprehensive review within the field of nasal drug delivery while reviewing the very latest new data and innovative technologies.

Nasal Drug Delivery Website

Respiratory Drug Delivery 2020 (RDD 2020)

26 -30 April 2020 | Palm Desert, CA, USA

Proveris is a Silver Sponsor of the Respiratory Drug Delivery (RDD) 2020 Conference. At our exhibit stand we’ll showcase our latest technology solutions and laboratory services for testing orally inhaled and nasal drug products (OINDPs). We’ll present study results in the Scientific Poster Session and we’ll have a private meeting room for the duration of the conference.

To schedule a meeting with us to discuss how we can help address your current challenges in OINDP development, email contactus@proveris.com.

Respiratory Drug Delivery, RDD®, hosts conferences in the US, Europe and Asia provide a venue for expert speakers to cover topics including: new therapeutic opportunities and drug delivery technologies, regulatory science and novel in vitro, in vivo and clinical testing methods.

RDD 2020 Website